Related Experiment Video
Updated: May 17, 2025

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
Small protein DDX11-AS1-ORF encoded by lncRNA DDX11-AS1 promotes colorectal cancer progression through
Yuanfang Cheng1, Jiajie Dong1, Kai Shang2
1Department of Biochemistry and Molecular Biology, Sanquan College of Xinxiang Medical University, School of Basic Medicine Xinxiang 453513, Henan, P. R. China.
Abstract:
This study aims to investigate the expression, function, and mechanism of action of the small protein DDX11 antisense RNA 1 - open reading frame (DDX11-AS1-ORF), encoded by the long non-coding RNA (lncRNA) DDX11 antisense RNA 1 (DDX11-AS1), in the progression of colorectal cancer (CRC). The expression levels of DDX11-AS1 were assessed by quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis in 10 pairs of colorectal cancer tissues and corresponding non-tumor tissues. Functional evaluations of DDX11-AS1 and DDX11-AS1-ORF were conducted using cell counting kit-8 (CCK8) assays, colony formation assays, Transwell migration assays, and in vitro tube formation assays. The coding potential of DDX11-AS1 was validated by western blot and immunofluorescence. The activation of the p38 mitogen-activated protein kinase (p38-MAPK) pathway by DDX11-AS1-ORF through VEGFA was analyzed using western blot. The results showed that DDX11-AS1 was significantly upregulated in colorectal cancer tissues and cells, promoting cancer cell proliferation, migration, and angiogenesis. DDX11-AS1 translated into a functional small protein, DDX11-AS1-ORF, which independently enhanced the malignant behaviors of tumor cells. DDX11-AS1-ORF promoted colorectal cancer progression by activating the p38-MAPK signaling pathway through Vascular Endothelial Growth Factor A (VEGFA). The critical role of the p38-MAPK pathway in DDX11-AS1-ORF mediated tumor promotion was confirmed using the p38-MAPK pathway inhibitor SB203580. In conclusion, the small protein DDX11-AS1-ORF, encoded by DDX11-AS1, plays a crucial role in the development of colorectal cancer by promoting tumor proliferation, migration, and angiogenesis through the activation of VEGFA and the p38-MAPK signaling pathway. These findings provide a novel potential target for molecular targeted therapy in colorectal cancer.
Insights
The small protein DDX11-AS1-ORF, encoded by DDX11-AS1, promotes colorectal cancer (CRC) progression. It enhances tumor proliferation, migration, and angiogenesis by activating the VEGFA/p38-MAPK pathway, offering a potential therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Cancer Research
Background:
- Colorectal cancer (CRC) progression involves complex molecular mechanisms.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- The functional role of small proteins encoded by lncRNAs in CRC remains underexplored.
Purpose of the Study:
- To investigate the expression, function, and mechanism of the small protein DDX11-AS1-ORF in colorectal cancer (CRC).
- To elucidate the role of DDX11-AS1 and its encoded protein in CRC progression.
- To identify potential therapeutic targets for CRC.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for gene expression analysis.
- Cell counting kit-8 (CCK8), colony formation, Transwell migration, and in vitro tube formation assays for functional evaluation.
- Western blot and immunofluorescence for protein validation and pathway analysis.
- Inhibition of the p38-MAPK pathway using SB203580.
Main Results:
- DDX11-AS1 was significantly upregulated in CRC tissues and cells.
- DDX11-AS1 translated into a functional small protein, DDX11-AS1-ORF, promoting CRC cell proliferation, migration, and angiogenesis.
- DDX11-AS1-ORF activated the p38-MAPK signaling pathway via VEGFA, driving tumor progression.
- Inhibition of p38-MAPK pathway suppressed DDX11-AS1-ORF-mediated tumor promotion.
Conclusions:
- The small protein DDX11-AS1-ORF, derived from DDX11-AS1, is a key driver of colorectal cancer.
- DDX11-AS1-ORF promotes CRC by enhancing proliferation, migration, and angiogenesis through the VEGFA/p38-MAPK pathway.
- DDX11-AS1-ORF represents a novel and promising molecular target for CRC therapy.
More Related Videos
12:37Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS
Published on: September 11, 2012
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...